| abstract |
Provided are: a novel compound having antiviral action, especially HIV replication inhibitory activity; and a pharmaceutical product, especially an anti-HIV agent which contains this compound.nA compound represented by formula (I).n(In the formula, A 3 represents CR 3A , CR 3A R 3B , N or NR 3C ; each of R 3A , R 3B , R 4A and R 4B independently represents a hydrogen atom, a halogen atom, a cyano group, a substituted or unsubstituted alkyl group, a substituted or unsubstituted alkynyl group or a substituted or unsubstituted non-aromatic carbocyclic group; R 3C represents a hydrogen atom, a substituted or unsubstituted alkyl group or a substituted or unsubstituted non-aromatic carbocyclic group; ring T 1 represents a substituted or unsubstituted nitrogen-containing non-aromatic heterocyclic ring; R 1 represents a hydrogen atom, a halogen atom, a cyano group or a substituted or unsubstituted alkyl group; each R 2 independently represents a substituted or unsubstituted alkyl group or the like; n represents 1 or 2; R 3 represents a substituted or unsubstituted aromatic carbocyclic group or the like; and R 4 represents a hydrogen atom or a carboxy-protecting group.) |